Good Signal Detection Practices: Evidence from IMI PROTECT

• Antoni F. Z. WisniewskiAstraZeneca (United Kingdom)
• Andrew BatePfizer (United Kingdom)
• Cédric Bousquet BInserm
• Andreas BruecknerNovartis (Switzerland)
• Gianmario CandoreEuropean Medicines Agency
• Kristina JuhlinUppsala Monitoring Centre
• Miguel Angel MaciáAgencia Española de Medicamentos y Productos Sanitarios
• Katrin Manlik
• Naashika QuarcooGlaxoSmithKline (United Kingdom)
• Suzie SeabrokeMedicines and Healthcare products Regulatory Agency
• Jim SlatteryEuropean Medicines Agency
• Harry Southworth
• Bharat T. ThakrarF. Hoffmann-La Roche AG
• Phil TregunnoMedicines and Healthcare products Regulatory Agency
• Lionel Van HolleGlaxoSmithKline (Belgium)
• Michael KayserBayer (Germany)
• G. Niklas NorénUppsala Monitoring Centre